VWR International purchases United Biochemicals

Published: 4-Jul-2013
Ingredients Finance Pharmaceutical

United Biochemicals manufactures buffers and biochemicals for research, development and manufacturing processes


VWR International, a global solutions provider of laboratory supplies, equipment and services, has extended its capabilities in the life sciences industry by acquiring United Biochemicals for an undisclosed sum.

Based in Sanborn, New York, US and founded in 1996, United Biochemicals manufactures high purity buffers and biochemicals for research, development and manufacturing processes to biotech, pharmaceutical, cell culture media and medical diagnostic industries.

President and CEO of VWR Manuel Brocke-Benz, said: ‘United Biochemicals is a strong compliment to VWR’s growing life sciences portfolio.

‘United Biochemicals’ manufacturing expertise, combined with VWR’s existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry.’

Fayyaz Hussain, President of United Biochemicals, added: ‘This acquisition will allow United Biochemicals to leverage VWR's global sales and marketing organization to grow our business.’

  • Companies:
  • Avantor Sciences
See more

You may also like

Media

Avantor and GeminiBio embark on partnership for bioproduction workflow solutions

Read more
The two US-based companies have entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
  3. Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
  4. Sanofi Pasteur launches 5-in-1 combination vaccine in China New vaccine Pentaxim reduces number of infant injections from 12 to four
  5. SeaBeLife awarded over €1.5 million in i-Nov innovation competition Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration

Upcoming event

Cleanroom Conference UK

22–23 May 2024 | Exhibition | Birmingham, UK See all

You may also like

Media

Avantor and GeminiBio embark on partnership for bioproduction workflow solutions

The two US-based companies have entered into an agreement with GeminiBio to deliver custom hydrated solutions and cell culture media to the biopharma industry
Manufacturing

Avantor and Cytovance collaborate on plasmid DNA supply

The collaboration extends Avantor’s offering of critical materials for vaccines and therapeutics focused on cell and gene therapy
Finance

Avantor completes acquisition of Masterflex

Based in Illinois, Masterflex manufactures of peristaltic pumps and aseptic single-use fluid transfer technologies
Pharmaceutical

Avantor acquires RIM Bio to expand single-use business into China

Avantor has acquired a China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications to start AMEA push
Finance

Avantor expands China footprint with RIM Bio acquisition

The manufacturer’s Changzhou, China facility will be Avantor's first single-use production plant in the AMEA region
Media

Avantor completes acquisition of VWR

Avantor, a global supplier of ultra-high-purity materials for the life sciences and advanced technology industries, announced the successful completion of its acquisition of VWR Corporation, an independent provider of product, supply chain and service solutions, for laboratory and production customers
Analysis

Avantor opens Korea life sciences research and applications facility

Avantor, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, recently opened a new life sciences research and applications laboratory in the GwangGyo district, Suwon, South Korea
Subscribe now